Tower Research Capital (TRC)’s Actuate Therapeutics ACTU Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACTU Stock Details ACTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$79	Sell
2025 Q1	$17.3K	Buy
2024 Q4	–	Sell
2024 Q3	$2.21K	Buy